ANEUVO Launches ASPIRE
ANEUVO Launches US Study of ExaStim, a Non-invasive Spinal Neuromodulation System to Evaluate its Safety and Effectiveness for Paralysis due to Spinal Cord Injury
The ASPIRE clinical study is designed to demonstrate the safety and efficacy of the ExaStim® TSS system using non-invasive spinal cord stimulation to improve/regain the motor function of individuals with SCI. A maximum of 140 patients will be enrolled at up to 14 sites in the U.S.